Prospective, Multi-Center Study Using Bearing nsPVA Embolization Particles for the Treatment of uTErine fibRoids With Uterine Artery Embolization
Status: Recruiting
Location: See all (4) locations...
Intervention Type: Device
Study Type: Observational
SUMMARY
This is a prospective, multicenter, observational, post-market clinical follow-up study in subjects treated with Bearing nsPVA Embolization Particles for uterine fibroid embolization. Data collection will include safety and performance outcome relating to the use of Bearing nsPVA, through 6 months.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: f
View:
• Adult women ≥ 18 years old at the time of enrollment.
• Subject has symptomatic uterine fibroid(s), suitable to embolization.
• Subject provides written informed consent.
Locations
United States
New York
Astra Vascular/Astra Vein Treatment Center
RECRUITING
Brooklyn
Other Locations
Australia
The Wesley Hospital
RECRUITING
Brisbane
Alfred Health
RECRUITING
Sydney
United Kingdom
Royal Gwent Hospital (Aneurin Bevan UHB)
RECRUITING
Newport
Contact Information
Primary
Molly Ryan
molly.ryan@merit.com
314-620-7095
Backup
Vicky Brunk
vicky.brunk@merit.com
Time Frame
Start Date: 2024-08-22
Estimated Completion Date: 2026-12
Participants
Target number of participants: 100
Related Therapeutic Areas
Sponsors
Leads: Merit Medical Systems, Inc.